Supplementary Figure 3 from Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis

Supplementary Figure S3. Interaction between tumor infiltrating immune cells and treatment arm in the study cohort (n=226; 80 pCR). Red diamond and line indicate Odds Ratio (OR) and its 95% confidence interval (CI) in the combination arm; blue diamond and line indicate OR and its 95% CI in single agent arm (trastuzumab or lapatinib).